Vicky Makker
0000-0001-9793-7614
Publication & Citation Trends
Publications
364 total
Open label, multicenter, phase 2 study of farletuzumab ecteribulin, a folate receptor alpha-targeting antibody-drug conjugate, alone and in combination with lenvatinib in platinum-resistant ovarian cancer
Cited by 0
Semantic Scholar
Trastuzumab deruxtecan (T-DXd) in pretreated patients (pts) with HER2-expressing bladder cancer: Final results from the bladder cancer cohort in Part 1 of DESTINY-PanTumor02 (DP-02).
Cited by 1
Semantic Scholar
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.
Cited by 0
Semantic Scholar
A Phase II Trial of Olaparib Plus Pembrolizumab in Patients with Recurrent Copy-Number High/p53-Abnormal Endometrial Cancer
Cited by 0
Semantic Scholar
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
Cited by 0
Semantic Scholar
Randomized Phase 3 study of first-line trastuzumab deruxtecan with rilvegostomig or pembrolizumab in patients with human epidermal growth factor receptor 2-expressing, mismatch repair-proficient, primary advanced or recurrent endometrial cancer: DESTINY-Endometrial01/GOG-3098/ENGOT-EN24
Cited by 0
Semantic Scholar
POST-(NEO)ADJUVANT THERAPY OUTCOMES WITH LENVATINIB PLUS PEMBROLIZUMAB IN PARTICIPANTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER: RESULTS FROM STUDY 309/KEYNOTE-775 AND ENGOT-EN9/LEAP-001
Cited by 0
Semantic Scholar
A phase II trial of pembrolizumab plus olaparib for the treatment of patients with persistent/recurrent endometrial cancers.
Cited by 0
Semantic Scholar
Research Topics
Endometrial and Cervical Cancer Treatments
(187)
Ovarian cancer diagnosis and treatment
(135)
HER2/EGFR in Cancer Research
(51)
Cancer Immunotherapy and Biomarkers
(41)
Endometriosis Research and Treatment
(37)
Affiliations
Université Claude Bernard Lyon 1
Roche (Switzerland)
St. Joseph's Hospital and Medical Center
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center